News und Analysen
Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal
Shares in Arrowhead Pharmaceuticals (NASDAQ: ARWR) rose by more than 27% in the week to Friday morning. The company's bold aim is to have "20 individual products, either partnered or wholly owned
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network – Revenue increased by more than 20% in the first half of 2025 despite challenging conditions
Analog Devices (ADI) Q3 2025 Earnings Transcript
Image source: The Motley Fool.
Wednesday, August 20, 2025 at 10 a.m. ET
Chairman, President, and Chief Executive Officer — Vincent Roche
Source Fool.com
Oerlikon successfully placed CHF 350 million dual-tranche senior unsecured bonds
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
Pharmaceutical companies regularly encounter substantial headwinds. Among the most significant are patent cliffs -- when therapies lose patent exclusivity, inviting cheaper generic or biosimilar
2 Dividend Stocks to Buy and Hold
We've seen several investing trends sweep through Wall Street in recent years, from excitement about the cannabis market to the artificial intelligence (AI) industry that's now dominating headlines
Swiss Re reports a net income of USD 2.6 billion for the first half of 2025
Swiss Re’s Life Guide adds guidance on repurposed longevity drugs
Wildfires and severe thunderstorms in the US drive global insured losses to USD 80 billion in first half of 2025, Swiss Re Institute estimates
Ad hoc announcement pursuant to Art. 53 LR News Release
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland confirms its growth momentum in the first half of 2025 and improves profitability
NAGRAVISION and Broadpeak Unite to Combat Live Sports Piracy with Real-Time Disruption Technology
Presentation of the 2025 half-year results for the Julius Baer Group
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
President Donald Trump's trade policies have caused tumult on Wall Street. The president has pushed for aggressive tariffs on imported goods in an attempt to bring manufacturing jobs back to the
Glencore Converts Shares in Century Aluminium, Remains Largest Shareholder
On July 2, 2025, Glencore International AG, which owns more than 10% in Century Aluminum Company(NASDAQ:CENX), reported the conversion of derivative securities into 16,477 shares at $19.42 per
US tariffs to slow both global economic and insurance premium growth, says Swiss Re Institute
The Niello Company Deploys RecovR ID Check to Stop Car Dealer ID Fraud in its Tracks
United Cloud Strengthens Streaming Security with Extension of NAGRAVISION Anti-Piracy Deal
ABB among TIME’s World’s Most Sustainable Companies
Holcim completes spin-off of North America business